FDA recall record

Piperacillin and Tazobactam for Injection USP 3.375 grams per vial, Single-Dose Vial recall — FDA D-1030-2018

Presence of Particulate Matter: identified as glass and silicone material

Class Iclassification
D-1030-2018official record ID
Jul 18, 2018report date

Recall record at a glance

Official recordD-1030-2018
CategoryDrug Recalls
ClassificationClass I
FDA record statusTerminated
Recalling firmAuroMedics Pharma LLC
Report dateJul 18, 2018
Recall initiation dateJul 2, 2018
Quantity73620 single-dose vials
LocationEast Windsor, NJ, United States

Official product description

Piperacillin and Tazobactam for Injection USP 3.375 grams per vial, Single-Dose Vial, Rx Only. Manufactured for: Auromedics Pharma LLC 6 Wheeling Road Dayton NJ 08810, Made in India. NDC 55150-120-30

Why the product was recalled

Presence of Particulate Matter: identified as glass and silicone material

Distribution information

Nationwide in the USA

How to read the classification

FDA Class I indicates a situation in which there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. The classification shown here comes directly from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.